Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model.
暂无分享,去创建一个
S. Desiderio | M. Borowitz | D. Huso | D. Small | A. Duffield | P. Aplan | Li Li | B. Nguyen | S. Greenblatt | C. Slape | R. Novak | Bao Nguyen
[1] D. Huso,et al. Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice. , 2011, Blood.
[2] A. Mead,et al. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. , 2011, Blood.
[3] R. Pieters,et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. , 2011, Blood.
[4] R. Marschalek,et al. Backtracking to birth of the NUP98-HOXD13 gene fusion in an infant acute myeloid leukemia , 2011, Leukemia.
[5] T. Taki,et al. High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes , 2010, Leukemia.
[6] N. Tosic,et al. Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review. , 2009, Cancer genetics and cytogenetics.
[7] P. Nguyen,et al. Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.
[8] Zhenhua Zhang,et al. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men. , 2008, Journal of the National Cancer Institute. Monographs.
[9] M. Konopleva,et al. Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. , 2008, Journal of the National Cancer Institute.
[10] R. Humphries,et al. Hox genes in hematopoiesis and leukemogenesis , 2007, Oncogene.
[11] P. Meltzer,et al. Constitutive Fms‐like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells , 2007, British journal of haematology.
[12] K. Takamiya,et al. Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model. , 2006, Blood.
[13] W. Hiddemann,et al. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. , 2006, Cancer cell.
[14] C. Civin,et al. C/EBPα directs monocytic commitment of primary myeloid progenitors , 2006 .
[15] A. Wan,et al. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. , 2006, Blood.
[16] Yan Zhou,et al. Lineage specification and plasticity in CD19− early B cell precursors , 2006, The Journal of experimental medicine.
[17] S. Bohlander,et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations , 2006, The Journal of experimental medicine.
[18] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[19] Zhenhua Zhang,et al. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. , 2005, Blood.
[20] C. Miething,et al. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model. , 2005, Blood.
[21] Hideaki Nakajima,et al. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. , 2005, The Journal of clinical investigation.
[22] M. L. Le Beau,et al. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. , 2005, Blood.
[23] Kyu-Tae Kim,et al. Internal tandem duplications of the FLT3 gene are present in leukemia stem cells. , 2004, Blood.
[24] P. Aplan,et al. The Role of NUP98 Gene Fusions in Hematologic Malignancy , 2004, Leukemia & lymphoma.
[25] A. Baron,et al. Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics , 2004, Leukemia.
[26] M. Levis,et al. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression. , 2004, Blood.
[27] R. Humphries,et al. Differential and Common Leukemogenic Potentials of Multiple NUP98-Hox Fusion Proteins Alone or with Meis1 , 2004, Molecular and Cellular Biology.
[28] H. Drexler,et al. Expression of HOX Genes in Acute Leukemia Cell Lines with and without MLL Translocations , 2004, Leukemia & lymphoma.
[29] L. Shih,et al. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia , 2004, Leukemia.
[30] P. Romeo,et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein , 2003, Nature Medicine.
[31] M. Levis,et al. FLT3: ITDoes matter in leukemia , 2003, Leukemia.
[32] L. Shih,et al. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. , 2002, Blood.
[33] J. Griffin,et al. The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.
[34] C. Peschle,et al. Expression pattern of HOXB6 homeobox gene in myelomonocytic differentiation and acute myeloid leukemia , 2002, Leukemia.
[35] T. Ley,et al. PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] G. Sauvageau,et al. HOXB4-Induced Expansion of Adult Hematopoietic Stem Cells Ex Vivo , 2002, Cell.
[37] M. Caligiuri,et al. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. , 2001, Cancer research.
[38] W. Berdel,et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. , 2000, Blood.
[39] B. Löwenberg,et al. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene , 2000, Leukemia.
[40] F. Melchers,et al. Identification of CD19(-)B220(+)c-Kit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow. , 2000, International immunology.
[41] J. Jönsson,et al. Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes. , 1999, Experimental hematology.
[42] T. Shows,et al. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. , 1998, Cancer research.
[43] M. Taniwaki,et al. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia , 1997, Leukemia.
[44] H. Kaneko,et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. , 1996, Leukemia.
[45] M. Ratajczak,et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. Winchester,et al. High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase , 1987, The Journal of experimental medicine.
[47] S. Nimer. Myelodysplastic syndromes. , 2008, Blood.
[48] C. Civin,et al. C/EBPalpha directs monocytic commitment of primary myeloid progenitors. , 2006, Blood.
[49] A. Wan,et al. The Flt 3 receptor tyrosine kinase collaborates with NUP 98-HOX fusions in Acute Myeloid Leukemia , 2006 .
[50] T. Ley,et al. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Allebach,et al. Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor , 2002, Leukemia.